Codes, Drugs, and Rock ‘n’ Roll
Europe has set the stage for safer supply chains with its Falsified Medicines Directive. Next, the spotlight could fall on using serialization to boost patient centricity.
Mark Davison |
If the pharmaceutical industry was a 70s rock band, drug discovery would be the singer: high profile but temperamental (and doesn’t always turn up). And the manufacturing and supply chain functions would be the bass player: essential but not typically a source of creativity or innovation (at least in the eyes of most executives).
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.